Gene Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030

The global gene synthesis market is experiencing rapid growth, primarily driven by strong research in next-generation sequencing and genomics, as well as a growing preference for personalized medicine. Gene synthesis is gaining popularity in molecular diagnosis for the treatment of genetic and infectious diseases, enabling the detection of genetic variations and predicting drug responsiveness. The rise in the global disease burden further propels the demand for gene synthesis, leading to innovation and collaboration in the market.

Rising Disease Burden Spurs Demand for Gene Synthesis Among Healthcare Providers and Patients

The increasing prevalence of chronic diseases on a global scale is fueling the demand for new and effective therapies. Healthcare providers (HCPs) and patients are turning to gene therapy as an optimal method for managing chronic and infectious diseases. Gene therapy offers the potential to improve the management of endemic and infectious ailments, aiding researchers in understanding drug resistance and screening targets for vaccine and therapeutic development. The use of gene synthetic constructs accelerates gene therapy through recombinant DNA technology, single-chain antibodies, and DNA & RNA ribozymes. These factors collectively drive the demand for gene synthesis, leading to profitable outcomes in the gene synthesis market.

Sound Demand for Accurate & Precise Diagnostics Opens New Business Prospects

Advancements in gene synthesis and synthetic DNA technology have led to breakthroughs in developing viable and effective solutions to combat a growing number of pathogens and associated diseases, including the COVID-19 virus. The emergence of new strains of SARS-CoV-2 has spurred the demand for targeted therapies, fueling the adoption of gene synthesis for screening purposes. Research institutions and facilities are increasingly using gene synthesis techniques to develop accurate diagnostics for new diseases. This approach supports medical testing providers in developing reliable and precise diagnostics for a wide range of conditions, contributing to the expansion of the global gene synthesis market.

North America to Sustain Dominance Across Global Gene Synthesis Market

North America, led by Canada and the United States, is expected to see significant growth in the gene synthesis market. The rising prevalence of chronic and genetic conditions has increased the demand for personalized medicine, creating new opportunities in the region’s gene synthesis market. Additionally, an advanced healthcare infrastructure, government support, rising investments in medical R&D, and strong economic growth are driving growth across North America’s gene synthesis market. The Asia Pacific region is also emerging as a promising market for gene synthesis, driven by robust medical innovation and increasing demand for DNA replication.

Leading Market Players

Key players in the global gene synthesis market include Genewiz Inc., Brooks Automation Inc., Merck KGaA, Biomatik, OriGene Technologies Inc., Eurofins Genomics, Integrated DNA Technologies Inc., ProteoGenix, Twist Bioscience, Thermo Fisher Scientific Inc., and GenScript.